AD Pipeline Watch: First Patient Enrolled in Phase 2b Trial of Evommune’s Oral MRGPRX2 Antagonist August 28, 2025
In Memoriam: Remembering Robert Sidbury, MD, MPH, and His Contributions to Pediatric Dermatology July 18, 2025
AD Pipeline Update: Turn Therapeutics Launches Trial Evaluating Its Topical IL-36/IL-31 Inhibitor for Eczema July 15, 2025
